The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
Read More Shortages, Drugs (Pharmaceuticals), Supply Chain, Generic Brands and Products, Chemotherapy, Federal Trade Commission, Health and Human Services Department, Khan, Lina
